The modified light chain of inter-alpha inhibitor/antibody fusion protein, MR1007, improves survival in the rabbit sepsis models

por Nakamura, Masaki, Takeuchi, Takashi, Yatagai, Yukiko, Naito, Katsuki, Shirakawa, Kamon, Hosaka, Yoshitaka, Furusako, Shoji
Publicado 2007

In vivo Antitumor Mechanism of Natural Human Tumor Necrosis Factor Involving a T Cell‐mediated Immunological Route

por Asami, Tetsuya, Imai, Meroni, Tanaka, Yasuo, Hosaka, Yoshitaka, Kato, Kazuharu, Nakamura, Norio, Horisawa, Yoshifumi, Ashida, Yoshikazu, Kanamori, Toshinori, Nobuhara, Masahiro, Kurimoto, Masashi
Publicado en Jpn J Cancer Res (1989)

A novel free fatty acid receptor 1 (GPR40/FFAR1) agonist, MR1704, enhances glucose‐dependent insulin secretion and improves glucose homeostasis in rats

por Tsuda, Naoto, Kawaji, Atsuko, Sato, Toshihiro, Takagi, Mitsuhiro, Higashi, Chika, Kato, Yutaka, Ogawa, Kumiko, Naba, Hiroyasu, Ohkouchi, Munetaka, Nakamura, Masaki, Hosaka, Yoshitaka, Sakaki, Junichi
Publicado en Pharmacol Res Perspect (2017)

A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex

por Takayama, Hiroshi, Hosaka, Yoshitaka, Nakayama, Kazuyuki, Shirakawa, Kamon, Naitoh, Katsuki, Matsusue, Tomokazu, Shinozaki, Mikihiko, Honda, Motoyasu, Yatagai, Yukiko, Kawahara, Tetsushi, Hirose, Jiro, Yokoyama, Tooru, Kurihara, Michiru, Furusako, Shoji
Publicado 2008